Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Safeplus International Holdings Limited

Healthcare US BIPH

16.46USD
-0.01(0.06%)

Last update at 2026-06-03T20:10:00Z

Day Range

16.3116.54
LowHigh

52 Week Range

15.1016.77
LowHigh

Fundamentals

  • Previous Close 16.47
  • Market Cap0.36M
  • Volume13875
  • P/E Ratio-
  • Dividend Yield7.55%
  • EBITDA-2.88926M
  • Revenue TTM0.68M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM -0.33244M
  • Diluted EPS TTM-0.09

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Income before tax 1953.00M 2029.00M 1935.00M 3333.00M 1195.00M
Minority interest - - - - -
Net income 57.00M 125.00M 87.00M 613.00M 121.00M
Selling general administrative 405.00M 413.00M 433.00M 406.00M 312.00M
Selling and marketing expenses - - - - -
Gross profit 5363.00M 4461.00M 3917.00M 3290.00M 2337.00M
Reconciled depreciation - - - - -
Ebit 4958.00M 4048.00M 3484.00M 2884.00M 2025.00M
Ebitda 8602.00M 6787.00M 5642.00M 4920.00M 3730.00M
Depreciation and amortization 3644.00M 2739.00M 2158.00M 2036.00M 1705.00M
Non operating income net other - - - - -
Operating income 4958.00M 4048.00M 3484.00M 2884.00M 2025.00M
Other operating expenses 16081.00M 13883.00M 10943.00M 8653.00M 6860.00M
Interest expense 3387.00M - - - -
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 270.00M 581.00M 560.00M 614.00M 291.00M
Total revenue 21039.00M 17931.00M 14427.00M 11537.00M 8885.00M
Total operating expenses 405.00M 413.00M 433.00M 406.00M 312.00M
Cost of revenue 15676.00M 13470.00M 10510.00M 8247.00M 6548.00M
Total other income expense net -3005.00000M -2019.00000M -1549.00000M 449.00M -830.00000M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Total assets 104590.00M 100784.00M 72969.00M 73961.00M 61331.00M
Intangible assets 14521.00M 15845.00M 11822.00M 14214.00M 11767.00M
Earning assets - - - - -
Other current assets -1821.00000M 1101.00M 1324.00M 600.00M 552.00M
Total liab 74737.00M 66768.00M 47415.00M 47570.00M 39658.00M
Total stockholder equity 5622.00M 6239.00M 6290.00M 6840.00M 5363.00M
Deferred long term liab - - - - -
Other current liab -1555.00000M 2881.00M 6121.00M 6368.00M 3857.00M
Common stock 6210.00M 6196.00M 6092.00M 6074.00M 5526.00M
Capital stock - - - - -
Retained earnings -3982.00000M -3246.00000M -2657.00000M -2125.00000M -2285.00000M
Other liab - - - - -
Good will 14101.00M 14488.00M 8789.00M 8979.00M 6634.00M
Other assets - - - - -
Cash 2071.00M 1857.00M 1279.00M 1406.00M 867.00M
Cash and equivalents - - - - -
Total current liabilities 1209.00M 11705.00M 8377.00M 8661.00M 5524.00M
Current deferred revenue - 2155.00M - - -
Net debt 49023.00M 48091.00M 32277.00M 31532.00M 26603.00M
Short term debt 610.00M 6571.00M 384.00M 416.00M 206.00M
Short long term debt - - - - -
Short long term debt total 51094.00M 49948.00M 33556.00M 32938.00M 27470.00M
Other stockholder equity - - - - -
Property plant equipment - - - - -
Total current assets 4029.00M 7979.00M 6686.00M 4896.00M 3711.00M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments 451.00M 801.00M 1128.00M 556.00M 574.00M
Net receivables 3779.00M 3666.00M 499.00M 448.00M 394.00M
Long term debt - - - - -
Inventory - 512.00M 531.00M 400.00M 221.00M
Accounts payable 2154.00M 2253.00M 1872.00M 1877.00M 1461.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2476.00M 2371.00M 1937.00M 1753.00M 992.00M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 10102.00M 7992.00M 2400.00M 2043.00M 1738.00M
Deferred long term asset charges - - - - -
Non current assets total 100561.00M 92805.00M 66283.00M 69065.00M 57620.00M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities -6901.00000M - - - -
Net borrowings - - - - -
Total cash from financing activities 2612.00M 9419.00M 56.00M -995.00000M 2126.00M
Change to operating activities - - - - -
Net income 57.00M 125.00M 125.00M 654.00M 156.00M
Change in cash 214.00M 578.00M -127.00000M 539.00M 40.00M
Begin period cash flow 1857.00M 1279.00M 1406.00M 867.00M 827.00M
End period cash flow 2071.00M 1857.00M 1279.00M 1406.00M 867.00M
Total cash from operating activities 4653.00M 4078.00M 3131.00M 2772.00M 2530.00M
Issuance of capital stock - - - - -
Depreciation 3644.00M 2739.00M 2158.00M 2036.00M 1705.00M
Other cashflows from investing activities -89.00000M - - - -
Dividends paid 1644.00M -739.00000M -698.00000M -649.00000M -623.00000M
Change to inventory - - - - -
Change to account receivables 136.00M -124.00000M -445.00000M -190.00000M 284.00M
Sale purchase of stock - -13.00000M - - -
Other cashflows from financing activities -3167.00000M 5325.00M -2597.00000M -1198.00000M 1241.00M
Change to netincome - - - - -
Capital expenditures 6812.00M 2487.00M 2775.00M 2067.00M 1472.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -226.00000M -595.00000M -562.00000M -201.00000M -131.00000M
Stock based compensation - - - - -
Other non cash items 1178.00M 1809.00M 1410.00M 283.00M 800.00M
Free cash flow -2159.00000M 1591.00M 356.00M 705.00M 1058.00M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
BIPH
Safeplus International Holdings Limited		 -0.01 0.06% 16.46 - - 0.96 0.59 0.53
ISRG
Intuitive Surgical Inc		 4.99 1.24% 407.29 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 - -% 196.12 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -0.98 0.99% 98.17 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 1.18 0.82% 145.61 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Biophan Technologies, Inc. develops and markets various technologies for the medical device industries. The company is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was founded in 1963 and is based in Pittsford, New York.

Safeplus International Holdings Limited

15 Schoen Place, Pittsford, NY, United States, 14534

Key Executives

Name Title Year Born
Ms. Margaret V. Russell Sec. and Treasurer 1965

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions